Featured Stories

8:45 PM Feb 21, 2019
Solid checkpoint for CARs

PD-L1 family member B7-H3 could put CAR T cells in play for a slew of difficult-to-treat solid tumors, including pediatric cancers that lack targeted therapies, according to a pair of preclinical studies published this year. But questions around the target’s safety will call for close attention to the therapeutic window.

The findings, from Stanford...

6:47 PM Feb 21, 2019
Expansion into TNBC

With an RNA-binding small molecule that sensitizes HER2-negative cancers to Herceptin, Matt Disney’s latest study adds to the growing arsenal of preclinical therapies against triple-negative breast cancer. The only problem is the molecule may run the risk of worsening a patient’s cancer before making it better.

Disney has been a pioneer in the growing...

Career Opportunities

BioCentury was founded 27 years ago by Karen Bernstein and David Flores to give the then-fledgling biotech industry analysis and commentary to support the creation of better medicines and innovative technologies for improving healthcare.

Our mission hasn’t changed, but our scope has. BioCentury is the leading global voice for CEOs and C-suite executives, VCs, regulators, public equity investors and other decision-makers throughout the global healthcare ecosystem. It is produced by a team of curious, creative writers and editors passionate about innovation from idea to patient. 

Our readers tell us we are unique and value our independent perspective.

We are always on the lookout for talented writers and editors who want to join this mission. Who want to influence the direction of the biopharmaceutical industry. And who want to help shape our future as we advance in a world of continuous publishing and evolving digital formats. 

We look for people who are curious, enthusiastic and creative. In particular, we seek people who are keen to challenge and be challenged, enjoy a fast-paced environment and thrive under the pressure of responding to current events intelligently in real time. 

We like people who speak up; we have animated discussions that help us develop original, insightful ways of covering international developments in science, medicine, business and finance, pinpoint crucial issues and identify important trends. A sense of humor also helps.

We hire people from many backgrounds: Our founders started out in political science and sports journalism; the rest of us are a hodge-podge from science, finance, industry and more. 

Our team is located throughout the U.S. and in the U.K. We are open to candidates who are motivated to do what we do, and work with colleagues across the U.S., Europe and Asia. 

More on BioCentury.

Editors

Editors are the bastion for ensuring articles are insightful, accurate, balanced, comprehensive, well written and rigorously researched. Editors often restructure stories, working with writers to produce content that has the intended impact and advances the thinking of our readers.

Editors work on short and long form content across all topics. We have assistant editors, associate editors, senior editors and executive editors. 

These positions appeal to people who are keen to understand and explain the big picture, are organized, enjoy working collaboratively to create well-ordered arguments, and are sticklers for detail. Our editors use critical thinking and deploy domain expertise to ensure the full, relevant context is included in every article.

News editors

News editors sit at the floodgates of today’s events, making coverage decisions based on the impact for our audience, and prioritizing stories according to our editorial objectives.

They develop original angles to go beyond the headlines, assign stories and oversee the daily production of well-reported and well-edited news items for a broad audience.  

These positions appeal to highly organized, flexible people, capable of juggling multiple balls at once. News editors work in one of the most fast-paced roles and need to be able to assert good judgment in a short time and reprioritize assignments efficiently. 

Writers

Writers are the life-blood of BioCentury: they create the content that drives the thinking of our readership. Writers develop original angles, build deep and extensive networks of sources, research topics and pitch ideas.

Curiosity is probably the most important quality; these positions appeal to people who like the challenge of finding leads, can turn ideas into well-articulated arguments and are good at critical thinking. 

The best writers will want to build the network and reputation that BioCentury has developed over the last two decades with pharma executives, innovators, VCs, public investors, regulatory leaders, policymakers and other decision-makers globally.

While all writers cover all topics and write for all our journals, most develop domain expertise in one or more fields, which may include finance, dealmaking, clinical development or drug development in Europe or China. 

If you are interested in our work, please send a cover letter explaining how you can contribute to BioCentury’s mission, along with a resume, to careers@biocentury.com